// App-Quantinova.ai

13988 2014 AHA : Class II Major Histocompatibility Complex Transactivator (CIITA) Knockdown Prevents Immune Rejection of Allogeneic Bone Marrow Stem Cells in Cardiac Regeneration

Researchers

Presenter

  • Xi-Ping Huang

Principal Investigators

  • Sanjiv Dhingra

  • Jian Guo

  • Zhuo Sun

  • Shu-hong Li

  • Richard D Weisel

  • Ren-Ke Li

Medical Centers

  • University Health Network/Toronto General Hospital Research Institute, Toronto, ON, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Lactate dehydrogenase

  • Interferon

Drug/Treatment

  • 5-Azacytidine

  • Interferon

  • Allopurinol

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved